197 related articles for article (PubMed ID: 28926587)
1. Functional characterization of zebrafish orthologs of the human Beta 3-Glucosyltransferase B3GLCT gene mutated in Peters Plus Syndrome.
Weh E; Takeuchi H; Muheisen S; Haltiwanger RS; Semina EV
PLoS One; 2017; 12(9):e0184903. PubMed ID: 28926587
[TBL] [Abstract][Full Text] [Related]
2. Peters plus syndrome mutations affect the function and stability of human β1,3-glucosyltransferase.
Zhang A; Venkat A; Taujale R; Mull JL; Ito A; Kannan N; Haltiwanger RS
J Biol Chem; 2021 Jul; 297(1):100843. PubMed ID: 34058199
[TBL] [Abstract][Full Text] [Related]
3. Peters plus syndrome mutations disrupt a noncanonical ER quality-control mechanism.
Vasudevan D; Takeuchi H; Johar SS; Majerus E; Haltiwanger RS
Curr Biol; 2015 Feb; 25(3):286-295. PubMed ID: 25544610
[TBL] [Abstract][Full Text] [Related]
4. ADAMTS9 and ADAMTS20 are differentially affected by loss of B3GLCT in mouse model of Peters plus syndrome.
Holdener BC; Percival CJ; Grady RC; Cameron DC; Berardinelli SJ; Zhang A; Neupane S; Takeuchi M; Jimenez-Vega JC; Uddin SMZ; Komatsu DE; Honkanen R; Dubail J; Apte SS; Sato T; Narimatsu H; McClain SA; Haltiwanger RS
Hum Mol Genet; 2019 Dec; 28(24):4053-4066. PubMed ID: 31600785
[TBL] [Abstract][Full Text] [Related]
5. Peters plus syndrome and Chorioretinal findings associated with B3GLCT gene mutation - a case report.
Wang YE; Ramirez DA; Chang TC; Berrocal A
BMC Ophthalmol; 2020 Mar; 20(1):118. PubMed ID: 32204707
[TBL] [Abstract][Full Text] [Related]
6. Contribution of a Novel
Totoń-Żurańska J; Kapusta P; Rybak-Krzyszkowska M; Lorenc K; Machlowska J; Skalniak A; Filipek E; Pawlik D; Wołkow PP
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795264
[TBL] [Abstract][Full Text] [Related]
7. Novel B3GALTL mutations in classic Peters plus syndrome and lack of mutations in a large cohort of patients with similar phenotypes.
Weh E; Reis LM; Tyler RC; Bick D; Rhead WJ; Wallace S; McGregor TL; Dills SK; Chao MC; Murray JC; Semina EV
Clin Genet; 2014 Aug; 86(2):142-8. PubMed ID: 23889335
[TBL] [Abstract][Full Text] [Related]
8. Hydrocephalus in mouse B3glct mutants is likely caused by defects in multiple B3GLCT substrates in ependymal cells and subcommissural organ.
Neupane S; Goto J; Berardinelli SJ; Ito A; Haltiwanger RS; Holdener BC
Glycobiology; 2021 Sep; 31(8):988-1004. PubMed ID: 33909046
[TBL] [Abstract][Full Text] [Related]
9. First functional analysis of a novel splicing mutation in the B3GALTL gene by an ex vivo approach in Tunisian patients with typical Peters plus syndrome.
Ben Mahmoud A; Siala O; Mansour RB; Driss F; Baklouti-Gargouri S; Mkaouar-Rebai E; Belguith N; Fakhfakh F
Gene; 2013 Dec; 532(1):13-7. PubMed ID: 23954224
[TBL] [Abstract][Full Text] [Related]
10. High-Throughput miRFluR Platform Identifies miRNA Regulating B3GLCT That Predict Peters' Plus Syndrome Phenotype, Supporting the miRNA Proxy Hypothesis.
Thu CT; Chung JY; Dhawan D; Vaiana CA; Mahal LK
ACS Chem Biol; 2021 Oct; 16(10):1900-1907. PubMed ID: 34085516
[TBL] [Abstract][Full Text] [Related]
11.
Zhang A; Berardinelli SJ; Leonhard-Melief C; Vasudevan D; Liu TW; Taibi A; Giannone S; Apte SS; Holdener BC; Haltiwanger RS
J Biol Chem; 2020 Nov; 295(46):15742-15753. PubMed ID: 32913123
[No Abstract] [Full Text] [Related]
12. Peters Plus syndrome: a recognizable clinical entity.
Demir GÜ; Lafcı NG; Doğan ÖA; Şimşek-Kiper PÖ; Utine GE
Turk J Pediatr; 2020; 62(1):136-140. PubMed ID: 32253880
[TBL] [Abstract][Full Text] [Related]
13. Two Tunisian patients with Peters plus syndrome harbouring a novel splice site mutation in the B3GALTL gene that modulates the mRNA secondary structure.
Siala O; Belguith N; Kammoun H; Kammoun B; Hmida N; Chabchoub I; Hchicha M; Fakhfakh F
Gene; 2012 Oct; 507(1):68-73. PubMed ID: 22759511
[TBL] [Abstract][Full Text] [Related]
14. Analyzing the Effects of O-Fucosylation on Secretion of ADAMTS Proteins Using Cell-Based Assays.
Berardinelli SJ; Haltiwanger RS
Methods Mol Biol; 2020; 2043():25-43. PubMed ID: 31463900
[TBL] [Abstract][Full Text] [Related]
15. Impaired ADAMTS9 secretion: A potential mechanism for eye defects in Peters Plus Syndrome.
Dubail J; Vasudevan D; Wang LW; Earp SE; Jenkins MW; Haltiwanger RS; Apte SS
Sci Rep; 2016 Sep; 6():33974. PubMed ID: 27687499
[TBL] [Abstract][Full Text] [Related]
16. Ocular Phenotype of Peters-Plus Syndrome.
Shah PR; Chauhan B; Chu CT; Kofler J; Nischal KK
Cornea; 2022 Feb; 41(2):219-223. PubMed ID: 34629439
[TBL] [Abstract][Full Text] [Related]
17. Loss of the AMD-associated B3GLCT gene affects glycosylation of TSP1 without impairing secretion in retinal pigment epithelial cells.
Lauwen S; Baerenfaenger M; Ruigrok S; de Jong EK; Wessels HJCT; den Hollander AI; Lefeber DJ
Exp Eye Res; 2021 Dec; 213():108798. PubMed ID: 34695439
[TBL] [Abstract][Full Text] [Related]
18. Hydrocephalus, agenesis of the corpus callosum, and cleft lip/palate represent frequent associations in fetuses with Peters' plus syndrome and B3GALTL mutations. Fetal PPS phenotypes, expanded by Dandy Walker cyst and encephalocele.
Schoner K; Kohlhase J; Müller AM; Schramm T; Plassmann M; Schmitz R; Neesen J; Wieacker P; Rehder H
Prenat Diagn; 2013 Jan; 33(1):75-80. PubMed ID: 23161355
[TBL] [Abstract][Full Text] [Related]
19. Genomic, cDNA and embryonic expression analysis of zebrafish IRF6, the gene mutated in the human oral clefting disorders Van der Woude and popliteal pterygium syndromes.
Ben J; Jabs EW; Chong SS
Gene Expr Patterns; 2005 Jun; 5(5):629-38. PubMed ID: 15939375
[TBL] [Abstract][Full Text] [Related]
20. Peters'-plus syndrome is a congenital disorder of glycosylation caused by a defect in the beta1,3-glucosyltransferase that modifies thrombospondin type 1 repeats.
Heinonen TY; Maki M
Ann Med; 2009; 41(1):2-10. PubMed ID: 18720094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
